Skip to main content

CareDx to Participate in Wells Fargo Healthcare Conference

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in a fireside chat at the Wells Fargo Healthcare Conference in Boston, Massachusetts, on September 5, 2025, at 8:00 AM ET.

A live and archived webcast of the presentation will be available on the “Events and Presentations” section of the CareDx investor relations website at investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit www.caredx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  224.21
+3.12 (1.41%)
AAPL  262.82
+3.24 (1.25%)
AMD  252.92
+17.93 (7.63%)
BAC  52.57
+0.81 (1.56%)
GOOG  260.51
+6.78 (2.67%)
META  738.36
+4.36 (0.59%)
MSFT  523.61
+3.05 (0.59%)
NVDA  186.26
+4.10 (2.25%)
ORCL  283.33
+3.26 (1.16%)
TSLA  433.72
-15.26 (-3.40%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.